| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1185 |
| 1 | PREDNISONE | 759 |
| 2 | INFLIXIMAB | 644 |
| 3 | METHOTREXATE SODIUM | 510 |
| 4 | VEDOLIZUMAB | 503 |
| 5 | METHOTREXATE | 430 |
| 6 | ASPIRIN | 390 |
| 7 | AZATHIOPRINE | 388 |
| 8 | ASPIRIN 325 MG | 368 |
| 9 | ASPIRIN 81 MG | 368 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MESALAMINE | 285 | 0.0101 |
| 1 | VEDOLIZUMAB | 503 | 0.0058 |
| 2 | AZATHIOPRINE | 388 | 0.0044 |
| 3 | NINTEDANIB | 137 | 0.0042 |
| 4 | MERCAPTOPURINE | 54 | 0.0031 |
| 5 | ADALIMUMAB-FKJP | 142 | 0.0031 |
| 6 | INFLIXIMAB | 644 | 0.0029 |
| 7 | ADALIMUMAB-ADAZ | 161 | 0.0029 |
| 8 | ADALIMUMAB-AATY | 145 | 0.0029 |
| 9 | METRONIDAZOLE | 175 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1549 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1165 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 895 |
| 3 | Aminosalicylate [EPC] | 529 |
| 4 | Integrin Receptor Antagonist [EPC] | 526 |
| 5 | Proton Pump Inhibitor [EPC] | 465 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 451 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 407 |
| 8 | Purine Antimetabolite [EPC] | 392 |
| 9 | Benzodiazepine [EPC] | 379 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 13 | 0.0189 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 24 | 0.0116 |
| 2 | Provitamin D2 Compound [EPC] | 295 | 0.0099 |
| 3 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |
| 4 | Integrin Receptor Antagonist [EPC] | 526 | 0.0060 |
| 5 | Interleukin-17A Antagonist [EPC] | 198 | 0.0053 |
| 6 | Aminosalicylate [EPC] | 529 | 0.0052 |
| 7 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 8 | Purine Antimetabolite [EPC] | 392 | 0.0040 |
| 9 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |